Overview
Semax is an ACTH-derived peptide analog built to isolate the neurotrophic and neuroprotective properties of the ACTH(4-7) core while bypassing the adrenal steroidogenic axis entirely. Its Pro-Gly-Pro C-terminal extension — itself a naturally occurring neuropeptide — adds protease resistance and independent neurotrophic activity, making the full sequence more than a simple ACTH fragment.
Mechanism of Action
In hippocampal and cortical preparations, Semax exposure upregulates BDNF and NGF expression — documented mRNA increases in the 1.6- to 2.2-fold range with corresponding mature protein elevation — alongside compensatory TrkB receptor upregulation. Downstream MAPK/ERK and PI3K/Akt cascade activation links this neurotrophic lift to the well-characterized pathways of synaptic plasticity and neuronal survival. In cerebral ischemia models, Semax has additionally been investigated for anti-apoptotic and antioxidant signaling activity.
Specifications
- Purity: ≥99% (HPLC) with mass-spectrometry identity confirmation
- Form: Lyophilized powder
- CAS Number: 80714-61-0
- Molecular Weight: 813.92 g/mol
- Chemical Formula: C₃₇H₅₁N₉O₁₀S
- Synonyms: ACTH(4-7)-PGP, N-Pro-Gly-Pro-ACTH(4-7)
Research Applications
- BDNF and NGF expression studies
- Synaptic plasticity and long-term potentiation models
- Neuroprotective and anti-apoptotic signaling research
- Oxidative stress and lipid peroxidation models
- ACTH fragment pharmacology



